Total Payments
$1,318
2024 Payments
$412.74
Companies
15
Transactions
68
Medicare Patients
1,791
Medicare Billing
$216,602
Payment Breakdown by Category
Food & Beverage$1,318 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,318 | 68 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $714.04 | 30 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $261.32 | 20 | $0 (2024) |
| Gilead Sciences, Inc. | $73.56 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $47.44 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $36.10 | 2 | $0 (2023) |
| Amgen Inc. | $31.81 | 1 | $0 (2022) |
| EISAI INC. | $21.77 | 1 | $0 (2022) |
| W. L. Gore & Associates, Inc. | $19.08 | 1 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $18.86 | 1 | $0 (2023) |
| Ceribell, Inc. | $17.82 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $412.74 | 17 | AstraZeneca Pharmaceuticals LP ($305.96) |
| 2023 | $341.07 | 17 | AstraZeneca Pharmaceuticals LP ($221.84) |
| 2022 | $511.25 | 31 | AstraZeneca Pharmaceuticals LP ($186.24) |
| 2021 | $52.83 | 3 | Gilead Sciences, Inc. ($18.15) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $34.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.17 | General |
| Category: Cardiovascular | ||||||
| 07/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.72 | General |
| Category: Cardiovascular | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Rare Disease | ||||||
| 05/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.57 | General |
| Category: Cardiovascular | ||||||
| 04/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: Cardiovascular | ||||||
| 04/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $17.82 | General |
| Category: Neurology | ||||||
| 12/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Cardiovascular | ||||||
| 10/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2023 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/31/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.63 | General |
| Category: Cardiovascular | ||||||
| 08/17/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 521 | 809 | $155,562 | $65,672 |
| 2022 | 9 | 960 | 1,419 | $255,392 | $114,782 |
| 2021 | 7 | 310 | 474 | $88,432 | $36,148 |
Total Patients
1,791
Total Services
2,702
Medicare Billing
$216,602
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 182 | 448 | $71,472 | $30,508 | 42.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 181 | 200 | $47,990 | $20,019 | 41.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 141 | 144 | $33,320 | $13,956 | 41.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 17 | 17 | $2,780 | $1,189 | 42.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 305 | 717 | $104,266 | $47,740 | 45.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 316 | 358 | $74,831 | $34,035 | 45.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 149 | 154 | $33,104 | $15,107 | 45.6% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 59 | 59 | $12,169 | $5,131 | 42.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 29 | $11,744 | $4,790 | 40.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $7,305 | $2,858 | 39.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 42 | 42 | $6,152 | $2,535 | 41.2% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 27 | 27 | $3,911 | $1,754 | 44.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 13 | 13 | $1,909 | $832.08 | 43.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 116 | 263 | $38,603 | $15,810 | 41.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 84 | 100 | $21,090 | $8,752 | 41.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 48 | 48 | $10,444 | $4,173 | 40.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $7,363 | $2,955 | 40.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 14 | 15 | $5,567 | $2,227 | 40.0% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 15 | 15 | $3,164 | $1,350 | 42.7% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 15 | 15 | $2,202 | $880.65 | 40.0% |
About Arfa Ahmad
Arfa Ahmad is a Internal Medicine healthcare provider based in Salisbury, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2018. The National Provider Identifier (NPI) number assigned to this provider is 1548756372.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Arfa Ahmad has received a total of $1,318 in payments from pharmaceutical and medical device companies, with $412.74 received in 2024. These payments were reported across 68 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,318).
As a Medicare-enrolled provider, Ahmad has provided services to 1,791 Medicare beneficiaries, totaling 2,702 services with total Medicare billing of $216,602. Data is available for 3 years (2021–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Salisbury, MD
- Active Since 07/04/2018
- Last Updated 07/01/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1548756372
Products in Payments
- FARXIGA (Drug) $377.07
- LOKELMA (Drug) $301.22
- ELIQUIS (Drug) $128.11
- CAMZYOS (Drug) $110.45
- XARELTO (Drug) $54.96
- ENTRESTO (Drug) $47.44
- Repatha (Biological) $31.81
- Lenvima (Drug) $21.77
- GORE CARDIOFORM Septal Occluder (Device) $19.08
- ANDEXXA (Biological) $18.34
- POCKET EEG DEVICE (Device) $17.82
- BRILINTA (Drug) $17.41
- Ozempic (Drug) $16.57
- FUROSCIX (Drug) $15.00
- GIVLAARI (Drug) $13.92
- Inpefa (Drug) $13.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Salisbury
Akhil Parashar, M.d, M.D
Internal Medicine — Payments: $48,967
Internal Medicine $48,967
Stacy Kennedy, M.d, M.D
Internal Medicine — Payments: $26,914
Internal Medicine $26,914
Dr. Robert Mcneill, M.d, M.D
Internal Medicine — Payments: $14,247
Internal Medicine $14,247
Karim Arnaout, M.d, M.D
Internal Medicine — Payments: $8,657
Internal Medicine $8,657
Dr. David Bearss, M.d, M.D
Internal Medicine — Payments: $7,098
Internal Medicine $7,098
Dr. Justin Kucinski, Do, DO
Internal Medicine — Payments: $7,018
Internal Medicine $7,018